| Dr Gerard Stanley Mason, OD | |
|
60 Wood Pond Rd, Glastonbury, CT 06033-3702 | |
| (860) 633-6236 | |
| Not Available |
| Full Name | Dr Gerard Stanley Mason |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 60 Wood Pond Rd, Glastonbury, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598821621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | CT719 (Connecticut) | Primary |
| Provider Name | Oculusdocs Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407490055 PECOS PAC ID: 0547694465 Enrollment ID: O20200102000580 |
News Archive
After handling raw poultry, hands of food preparers and cutting boards remain a source of transmission for multi-drug resistant bacteria, such as E. coli that produce extended-spectrum beta-lactamases (ESBLs).
According to a new study two "screen and treat" cervical cancer prevention programs developed for high-risk women in low-resource settings resulted in a lower prevalence of precancerous cervical lesions and cervical cancer, according to a study in the November 2 issue of JAMA: The Journal of the American Medical Association.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerard Stanley Mason, OD 60 Wood Pond Rd, Glastonbury, CT 06033-3702 Ph: (860) 633-6236 | Dr Gerard Stanley Mason, OD 60 Wood Pond Rd, Glastonbury, CT 06033-3702 Ph: (860) 633-6236 |
News Archive
After handling raw poultry, hands of food preparers and cutting boards remain a source of transmission for multi-drug resistant bacteria, such as E. coli that produce extended-spectrum beta-lactamases (ESBLs).
According to a new study two "screen and treat" cervical cancer prevention programs developed for high-risk women in low-resource settings resulted in a lower prevalence of precancerous cervical lesions and cervical cancer, according to a study in the November 2 issue of JAMA: The Journal of the American Medical Association.
According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.
Tioga Pharmaceuticals, Inc. announced today that the company has dosed its first subject in a Phase 3 clinical trial to evaluate asimadoline for the treatment of patients with diarrhea-predominant irritable bowel syndrome (DIBS). The trial, referred to as ASMP3001, is the first of two Phase 3 trials being conducted under a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for U.S. registration. This first trial will be conducted at 120 sites in the U.S.
› Verified 7 days ago
Oculusdocs, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 221 Addison Rd Ste 105, Glastonbury, CT 06033 Phone: 860-838-3838 Fax: 860-838-3840 | |
Susan C Danberg Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 212 New London Tpke, Glastonbury, CT 06033 Phone: 860-657-9189 | |
Connecticut Childrens Eye Care Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 131 New London Tpke Ste 200, Glastonbury, CT 06033 Phone: 860-837-9600 | |
D&l Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 Welles Street, Glastonbury, CT 06033 Phone: 860-633-1401 | |
Glastonbury Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2377 Main St, Glastonbury, CT 06033 Phone: 860-633-7889 | |
Solinsky Eyecare Llc Optometrist Medicare: Medicare Enrolled Practice Location: 55 Nye Rd Ste 104, Glastonbury, CT 06033 Phone: 860-633-6634 Fax: 860-236-4979 | |
David R Cartwright, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 63 Hebron Ave Ste E, Glastonbury, CT 06033 Phone: 860-659-5900 Fax: 860-659-9900 |